{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:16:27Z","timestamp":1787987787257,"version":"build-2784847793"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s40620-021-01010-4","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T05:02:52Z","timestamp":1615352572000},"page":"1907-1913","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Thrombotic microangiopathy versus class IV lupus nephritis in systemic lupus erythematosus"],"prefix":"10.1093","volume":"34","author":[{"given":"Momin H.","family":"Alkhatib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Kant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Menez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher John","family":"Sperati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek M.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois J.","family":"Arend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed G.","family":"Atta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"issue":"1","key":"1010_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/0961203312463110","volume":"22","author":"DE Furst","year":"2013","unstructured":"Furst DE, Clarke AE, Fernandes AW, Bancroft T, Greth W, Iorga SR (2013) Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population. Lupus 22(1):99\u2013105","journal-title":"Lupus"},{"issue":"8","key":"1010_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrneph.2017.85","volume":"13","author":"F Yu","year":"2017","unstructured":"Yu F, Haas M, Glassock R, Zhao MH (2017) Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol 13(8):483\u2013495","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1010_CR3","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/ar4142","volume":"15","author":"D Song","year":"2013","unstructured":"Song D, Wu LH, Wang FM, Yang XW, Zhu D, Chen M et al (2013) The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthr Res Ther 15(1):R12","journal-title":"Arthr Res Ther"},{"issue":"5","key":"1010_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/RHU.0000000000000425","volume":"22","author":"A Barrera-Vargas","year":"2016","unstructured":"Barrera-Vargas A, Rosado-Canto R, Merayo-Chalico J, Arreola-Guerra JM, Mejia-Vilet JM, Correa-Rotter R et al (2016) Renal thrombotic microangiopathy in proliferative lupus nephritis: risk factors and clinical outcomes: a case-control study. J Clin Rheumatol 22(5):235\u2013240","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"1010_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol JASN 15(2):241\u2013250","journal-title":"J Am Soc Nephrol JASN"},{"issue":"2","key":"1010_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1681\/ASN.V102413","volume":"10","author":"JS Cameron","year":"1999","unstructured":"Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol JASN 10(2):413\u2013424","journal-title":"J Am Soc Nephrol JASN"},{"issue":"1","key":"1010_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10157-015-1179-y","volume":"20","author":"TF Imran","year":"2016","unstructured":"Imran TF, Yick F, Verma S, Estiverne C, Ogbonnaya-Odor C, Thiruvarudsothy S et al (2016) Lupus nephritis: an update. Clin Exp Nephrol 20(1):1\u201313","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"1010_CR8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371(7):654\u2013666","journal-title":"N Engl J Med"},{"issue":"4","key":"1010_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2215\/CJN.11470918","volume":"14","author":"G Bayer","year":"2019","unstructured":"Bayer G, von Tokarski F (2019) Etiology outcomes of thrombotic microangiopathies. Clin J Am Soc Nephrol 14(4):557\u2013566","journal-title":"Clin J Am Soc Nephrol"},{"issue":"14","key":"1010_CR10","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1177\/0961203310376523","volume":"19","author":"W Hu","year":"2010","unstructured":"Hu W, Liu Z, Chen H, Zhang H, Li L, Liu Z (2010) Clinical characteristics and prognosis of diffuse proliferative lupus nephritis with thrombotic microangiopathy. Lupus 19(14):1591\u20131598. https:\/\/doi.org\/10.1177\/0961203310376523","journal-title":"Lupus"},{"issue":"1","key":"1010_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13052-019-0641-y","volume":"45","author":"J Li","year":"2019","unstructured":"Li J, Jiang JJ, Wang CY, Jian S, Zhou Y, Ma MS et al (2019) Clinical features and prognosis of patients with thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a review of 25 cases. Ital J Pediatr 45(1):55","journal-title":"Ital J Pediatr"},{"key":"1010_CR12","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3899\/jrheum.180773","volume":"46","author":"C Li","year":"2019","unstructured":"Li C, Yap DYH, Chan G, Wen YB, Li H, Tang C et al (2019) Clinical outcomes and clinico-pathological correlations in lupus nephritis with kidney biopsy showing thrombotic microangiopathy. J Rheumatol 46:1478\u201384","journal-title":"J Rheumatol"},{"issue":"17","key":"1010_CR13","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361(17):1676\u20131687","journal-title":"N Engl J Med"},{"issue":"2","key":"1010_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.imbio.2016.10.014","volume":"222","author":"P Farkas","year":"2017","unstructured":"Farkas P, Csuka D, Mikes B, Sinkovits G, Reti M, Nemeth E et al (2017) Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies. Immunobiology 222(2):119\u2013127","journal-title":"Immunobiology"},{"issue":"10","key":"1010_CR15","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1182\/blood-2017-05-782870","volume":"130","author":"NJ Gloude","year":"2017","unstructured":"Gloude NJ, Khandelwal P, Luebbering N, Lounder DT, Jodele S, Alder MN et al (2017) Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD. Blood 130(10):1259\u20131266","journal-title":"Blood"},{"issue":"3","key":"1010_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1053\/j.seminhematol.2018.04.003","volume":"55","author":"S Jodele","year":"2018","unstructured":"Jodele S (2018) Complement in pathophysiology and treatment of transplant-associated thrombotic microangiopathies. Semin Hematol 55(3):159\u2013166","journal-title":"Semin Hematol"},{"issue":"2","key":"1010_CR17","first-page":"220","volume":"54","author":"CW Teoh","year":"2016","unstructured":"Teoh CW, Riedl M, Licht C (2016) The alternative pathway of complement and the thrombotic microangiopathies. J World Apheresis Assoc 54(2):220\u2013231","journal-title":"J World Apheresis Assoc"},{"issue":"6","key":"1010_CR18","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.kint.2016.12.009","volume":"91","author":"S Timmermans","year":"2017","unstructured":"Timmermans S, Abdul-Hamid MA, Vanderlocht J, Damoiseaux J, Reutelingsperger CP, van Paassen P (2017) Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities. Kidney Int 91(6):1420\u20131425","journal-title":"Kidney Int"},{"issue":"3","key":"1010_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40620-016-0357-7","volume":"30","author":"A Asif","year":"2017","unstructured":"Asif A, Nayer A, Haas CS (2017) Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab. J Nephrol 30(3):347\u2013362","journal-title":"J Nephrol"},{"issue":"12","key":"1010_CR20","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s10067-017-3823-2","volume":"36","author":"MI de Holanda","year":"2017","unstructured":"de Holanda MI, Porto LC, Wagner T, Christiani LF, Palma LMP (2017) Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review. Clin Rheumatol 36(12):2859\u20132867","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1010_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","volume":"89","author":"LA Greenbaum","year":"2016","unstructured":"Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P et al (2016) Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int 89(3):701\u2013711","journal-title":"Kidney Int"},{"issue":"2","key":"1010_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10157-015-1142-y","volume":"20","author":"N Ito","year":"2016","unstructured":"Ito N, Hataya H, Saida K, Amano Y, Hidaka Y, Motoyoshi Y et al (2016) Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan. Clin Exp Nephrol 20(2):265\u2013272","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"1010_CR23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ki.2014.423","volume":"87","author":"C Licht","year":"2015","unstructured":"Licht C, Greenbaum LA, Muus P, Babu S, Bedrosian CL, Cohen DJ et al (2015) Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies. Kidney Int 87(5):1061\u20131073","journal-title":"Kidney Int"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-01010-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-021-01010-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-01010-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:40Z","timestamp":1777564480000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/34\/6\/1907\/8325690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1010"],"URL":"https:\/\/doi.org\/10.1007\/s40620-021-01010-4","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"10 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by Institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}